RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 123 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $119,000 | -44.1% | 6,078 | -38.1% | 0.01% | -57.1% |
| Q3 2020 | $213,000 | +2942.9% | 9,824 | +3230.2% | 0.01% | – |
| Q2 2020 | $7,000 | -30.0% | 295 | -54.9% | 0.00% | -100.0% |
| Q1 2020 | $10,000 | +25.0% | 654 | +81.2% | 0.00% | – |
| Q4 2019 | $8,000 | +300.0% | 361 | +375.0% | 0.00% | – |
| Q2 2019 | $2,000 | -87.5% | 76 | -87.0% | 0.00% | -100.0% |
| Q4 2018 | $16,000 | -15.8% | 583 | -12.5% | 0.00% | 0.0% |
| Q3 2018 | $19,000 | -99.7% | 666 | +223.3% | 0.00% | 0.0% |
| Q2 2018 | $6,440,000 | +107233.3% | 206 | -8.4% | 0.00% | 0.0% |
| Q4 2017 | $6,000 | – | 225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $11,875,000 | 2.75% |
| RA Capital Management | 4,871,067 | $63,616,000 | 0.88% |
| NEA Management Company, LLC | 4,912,306 | $64,155,000 | 0.76% |
| Samsara BioCapital, LLC | 300,293 | $3,922,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,989,625 | $25,985,000 | 0.51% |
| Baker Brothers Advisors | 3,863,239 | $50,454,000 | 0.22% |
| ACT CAPITAL MANAGEMENT, LLC | 31,000 | $405,000 | 0.21% |
| Rock Springs Capital Management LP | 612,180 | $7,995,000 | 0.17% |
| GILDER GAGNON HOWE & CO LLC | 1,496,424 | $19,543,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,011,053 | $39,324,000 | 0.08% |